<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29222403</article-id>
<article-id pub-id-type="pmc">5783968</article-id>
<article-id pub-id-type="publisher-id">1305-17</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.1305-17.2017</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group>
<subject>Neurobiology of Disease</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Common Pathophysiology in Multiple Mouse Models of Pitt–Hopkins Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-6733-369X</contrib-id>
<name>
<surname>Thaxton</surname>
<given-names>Courtney</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kloth</surname>
<given-names>Alexander D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Clark</surname>
<given-names>Ellen P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moy</surname>
<given-names>Sheryl S.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chitwood</surname>
<given-names>Raymond A.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2746-9143</contrib-id>
<name>
<surname>Philpot</surname>
<given-names>Benjamin D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Department of Cell Biology and Physiology, </aff>
<aff id="aff2"><sup>2</sup>Neuroscience Center, </aff>
<aff id="aff3"><sup>3</sup>Department of Psychiatry, </aff>
<aff id="aff4"><sup>4</sup>Carolina Institute for Developmental Disabilities, the University of North Carolina, Chapel Hill, North Carolina 27599, and </aff>
<aff id="aff5"><sup>5</sup>Center for Learning and Memory, Department of Neuroscience, University of Texas, Austin, Texas 78712</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Dr. Benjamin D. Philpot,
<addr-line>University of North Carolina School of Medicine, 115 Mason Farm Road, Chapel Hill, NC 27599-7545.</addr-line><email>bphilpot@med.unc.edu</email></corresp>
<fn fn-type="con">
<p>Author contributions: C.T., A.D.K., S.S.M., R.A.C., and B.D.P. designed research; C.T., A.D.K., E.P.C., S.S.M., and R.A.C. performed research; C.T., A.D.K., S.S.M., and R.A.C. analyzed data; C.T., A.D.K., and B.D.P. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="FN1">
<p>*C.T. and A.D.K. contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>24</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>24</day>
<month>7</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>38</volume>
<issue>4</issue>
<fpage>918</fpage>
<lpage>936</lpage>
<history>
<date date-type="received">
<day>10</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>8</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 the authors 0270-6474/18/380918-19$15.00/0</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns00418000918.pdf"></self-uri>
<abstract>
<p>Mutations or deletions of the transcription factor <italic>TCF4</italic> are linked to Pitt–Hopkins syndrome (PTHS) and schizophrenia, suggesting that the precise pathogenic mutations dictate cellular, synaptic, and behavioral consequences. Here, we generated two novel mouse models of PTHS, one that mimics the most common pathogenic <italic>TCF4</italic> point mutation (human R580W, mouse R579W) and one that deletes three pathogenic arginines, and explored phenotypes of these lines alongside models of pan-cellular or CNS-specific heterozygous <italic>Tcf4</italic> disruption. We used mice of both sexes to show that impaired <italic>Tcf4</italic> function results in consistent microcephaly, hyperactivity, reduced anxiety, and deficient spatial learning. All four PTHS mouse models demonstrated exaggerated hippocampal long-term potentiation (LTP), consistent with deficits in hippocampus-mediated behaviors. We further examined R579W mutant mice and mice with pan-cellular <italic>Tcf4</italic> heterozygosity and found that they exhibited hippocampal NMDA receptor hyperfunction, which likely drives the enhanced LTP. Together, our data pinpoint convergent neurobiological features in PTHS mouse models and provide a foundation for preclinical studies and a rationale for testing whether NMDAR antagonists might be used to treat PTHS.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Pitt–Hopkins syndrome (PTHS) is a rare neurodevelopmental disorder associated with <italic>TCF4</italic> mutations/deletions. Despite this genetic insight, there is a need to identify the function of TCF4 in the brain. Toward this goal, we developed two mouse lines, including one harboring the most prevalent pathogenic point mutation, and compared them with two existing models that conditionally delete <italic>Tcf4</italic>. Our data identify a set of overlapping phenotypes that may serve as outcome measures for preclinical studies of PTHS treatments. We also discovered penetrant enhanced synaptic plasticity across mouse models that may be linked to increased NMDA receptor function. These data reveal convergent neurobiological characteristics of PTHS mouse models and support the further investigation of NMDA receptor antagonists as a possible PTHS treatment.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>mouse</kwd>
<kwd>NMDA</kwd>
<kwd>Pitt–Hopkins syndrome</kwd>
<kwd>schizophrenia</kwd>
<kwd>TCF4</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>